These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23294797)

  • 1. Reimbursement for continuous glucose monitoring: a European view.
    Heinemann L; Franc S; Phillip M; Battelino T; Ampudia-Blasco FJ; Bolinder J; Diem P; Pickup J; Hans Devries J
    J Diabetes Sci Technol; 2012 Nov; 6(6):1498-502. PubMed ID: 23294797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reimbursement for Continuous Glucose Monitoring.
    Heinemann L; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S248-52. PubMed ID: 26784130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective.
    Sumnik Z; Szypowska A; Iotova V; Bratina N; Cherubini V; Forsander G; Jali S; Raposo JF; Stipančic G; Vazeou A; Veeze H; Lange K;
    Pediatr Diabetes; 2019 Jun; 20(4):434-443. PubMed ID: 30773756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for continuous glucose monitoring: sufficient for reimbursement?
    Heinemann L; DeVries JH
    Diabet Med; 2014 Feb; 31(2):122-5. PubMed ID: 24152416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes.
    Fonda SJ; Graham C; Munakata J; Powers JM; Price D; Vigersky RA
    J Diabetes Sci Technol; 2016 Jul; 10(4):898-904. PubMed ID: 26843480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reimbursement Pathways for New Diabetes Technologies in Europe: Top-Down Versus Bottom-Up.
    Seidel D; Boggio Mesnil F; Caruso A
    J Diabetes Sci Technol; 2019 Jan; 13(1):118-122. PubMed ID: 30033750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reimbursement and coverage implications for CGM.
    Aubry W
    Diabetes Technol Ther; 2005 Oct; 7(5):797-800. PubMed ID: 16241886
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-Effectiveness of a Continuous Glucose Monitoring Mobile App for Patients With Type 2 Diabetes Mellitus: Analysis Simulation.
    Tsuji S; Ishikawa T; Morii Y; Zhang H; Suzuki T; Tanikawa T; Nakaya J; Ogasawara K
    J Med Internet Res; 2020 Sep; 22(9):e16053. PubMed ID: 32940613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England.
    Perera R; Oliver N; Wilmot E; Marriott C
    Diabet Med; 2018 Nov; 35(11):1617-1618. PubMed ID: 29931731
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of reimbursement in the adoption of continuous glucose monitors.
    Bartelme A; Bridger P
    J Diabetes Sci Technol; 2009 Jul; 3(4):992-5. PubMed ID: 20144351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future of diabetes-technology: certificate of competency for insulin pumps and continuous glucose monitors.
    Heinemann L; Faber-Heinemann G; Roberts R; Walsh J
    J Diabetes Sci Technol; 2012 Jul; 6(4):725-7. PubMed ID: 22920796
    [No Abstract]   [Full Text] [Related]  

  • 13. Third-party reimbursement for diabetes care, self-management education, and supplies.
    American Diabetes Association
    Diabetes Care; 2005 Jan; 28 Suppl 1():S62-3. PubMed ID: 15618117
    [No Abstract]   [Full Text] [Related]  

  • 14. Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with Type 1 diabetes.
    Murphy HR; Feig DS; Sanchez JJ; de Portu S; Sale A;
    Diabet Med; 2019 Dec; 36(12):1652-1658. PubMed ID: 31162713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefits, limitations, and cost-effectiveness of advanced technologies in the management of patients with diabetes mellitus.
    Vigersky RA
    J Diabetes Sci Technol; 2015 Mar; 9(2):320-30. PubMed ID: 25555391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges.
    Wood A; O'Neal D; Furler J; Ekinci EI
    Intern Med J; 2018 May; 48(5):499-508. PubMed ID: 29464891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.
    Fonseca VA; Grunberger G; Anhalt H; Bailey TS; Blevins T; Garg SK; Handelsman Y; Hirsch IB; Orzeck EA; Roberts VL; Tamborlane W;
    Endocr Pract; 2016 Aug; 22(8):1008-21. PubMed ID: 27214060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
    Roze S; Isitt J; Smith-Palmer J; Javanbakht M; Lynch P
    Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Choosing effective laboratory tests for diabetes care, and the reimbursement system].
    Ishii S; Kumasaka K
    Rinsho Byori; 2001 Dec; 49(12):1218-23. PubMed ID: 11797391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.